117 related articles for article (PubMed ID: 3133011)
1. Chemotherapy for carcinoma in situ of the bladder.
Jenkins BJ; England HR; Fowler CG; Tiptaft RC; Badenoch DF; Paris AM; Oliver RT; Blandy JP
Br J Urol; 1988 Apr; 61(4):326-9. PubMed ID: 3133011
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
Rintala E; Jauhiainen K; Alfthan O
Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
[No Abstract] [Full Text] [Related]
3. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
4. Intravesical mitomycin C for carcinoma in situ of the urinary bladder.
Hellsten S; Månsson W; Henrikson H; Idwall I; Lindholm K; Mikulowski P; Mårtensson S; Oldbring J
Scand J Urol Nephrol; 1990; 24(1):35-8. PubMed ID: 2108491
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
Giesbers AA; Van Helsdingen PJ; Kramer AE
Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
[TBL] [Abstract][Full Text] [Related]
6. Topical mitomycin C therapy for carcinoma in situ of the bladder: a followup.
Stricker PD; Grant AB; Hosken BM; Taylor JS
J Urol; 1990 Jan; 143(1):34-5; discussion 35-6. PubMed ID: 2104637
[TBL] [Abstract][Full Text] [Related]
7. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
8. Intravesical chemotherapy for carcinoma in situ of the urinary bladder: 5 years later.
Jakse G
Eur Urol; 1984; 10(5):289-93. PubMed ID: 6440791
[TBL] [Abstract][Full Text] [Related]
9. Intravesical mitomycin C and superficial bladder tumors.
Biserte J; Rigot JM; Mauroy B; Mazeman E
Prog Clin Biol Res; 1989; 303():411-5. PubMed ID: 2506555
[No Abstract] [Full Text] [Related]
10. BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands.
van der Meijden PM; Debruyne FM; Steerenberg PA; de Jong WH; Doesburg W
Prog Clin Biol Res; 1989; 310():285-98. PubMed ID: 2505272
[No Abstract] [Full Text] [Related]
11. Intravesical combination chemotherapy with mitomycin C and doxorubicin for carcinoma in situ of the bladder.
Fukui I; Sekine H; Kihara K; Yamada T; Takeuchi S; Yokokawa M; Kawai T; Hosoda K; Ohwada F; Suzuki S
J Urol; 1989 Mar; 141(3):531-4. PubMed ID: 2493099
[TBL] [Abstract][Full Text] [Related]
12. Topical mitomycin C therapy for carcinoma of the bladder.
Stricker PD; Grant AB; Hosken BM; Taylor JS
J Urol; 1987 Nov; 138(5):1164-6. PubMed ID: 3118056
[TBL] [Abstract][Full Text] [Related]
13. Cystectomy: the treatment of choice in patients with carcinoma in situ of the urinary bladder?
Jakse G; Putz A; Feichtinger J
Eur J Surg Oncol; 1989 Jun; 15(3):211-6. PubMed ID: 2737308
[TBL] [Abstract][Full Text] [Related]
14. Management of superficial G2 (pTa and pT1) bladder cancer.
Thorpe AC; Jenkins BJ; Martin JE
Urology; 1990 Nov; 36(5):395-7. PubMed ID: 2238296
[TBL] [Abstract][Full Text] [Related]
15. Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ: is it safe?
Droller MJ; Walsh PC
J Urol; 1985 Dec; 134(6):1115-7. PubMed ID: 3932686
[TBL] [Abstract][Full Text] [Related]
16. [Sequential instillation therapy with mitomycin-C and adriamycin in superficial bladder tumor with special reference to fate of 43 patients achieving complete response].
Fukui I; Sekine H; Kihara K; Yamada T; Kawai T; Washizuka M; Ishiwata D; Oka K; Hosoda K; Ikegami S
Nihon Hinyokika Gakkai Zasshi; 1987 Sep; 78(9):1539-44. PubMed ID: 3127621
[No Abstract] [Full Text] [Related]
17. Carcinoma in situ associated with superficial bladder tumor.
Solsona E; Iborra I; Ricós JV; Monrós JL; Dumont R; Casanova J; Calabuig C
Eur Urol; 1991; 19(2):93-6. PubMed ID: 1902418
[TBL] [Abstract][Full Text] [Related]
18. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder.
Merz VW; Marth D; Kraft R; Ackermann DK; Zingg EJ; Studer UE
Br J Urol; 1995 Feb; 75(2):180-4. PubMed ID: 7850322
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C in superficial bladder cancer: 24-month follow-up.
Somerville JJ; Newling DW; Richards B; Robinson MR; Smith PH
Br J Urol; 1985 Dec; 57(6):686-9. PubMed ID: 3936564
[TBL] [Abstract][Full Text] [Related]
20. Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
Soloway MS
J Urol; 1985 Dec; 134(6):1107-9. PubMed ID: 3932684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]